EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exocytosed ATP as a therapeutic target for inflammatory and metabolic diseases

Nao Hasuzawa, Seiji Nomura, Sawako Moriyama, Yoshinori Moriyama, Masatoshi Nomura

Frontiers in Pharmacology · 01.07.2026 · 17

DOI: 10.3389/fphar.2026.1856512 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 01.07.2026. Verfasst von Nao Hasuzawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan. Die Arbeit nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular adenosine triphosphate (eATP) is a key intercellular signaling molecule in purinergic transmission and contributes to pain, inflammation, and tissue dysfunction in a wide range of diseases. Although eATP is released through membrane damage, conductive pathways, and vesicular exocytosis, the biological and pharmacological significance of ATP released by exocytosis has remained insufficiently defined. Vesicular nucleotide transporter (VNUT), encoded by SLC17A9, which loads ATP into secretory vesicles, is essential for ATP exocytosis and has enabled direct investigation of the roles of exocytosed ATP in physiology and disease. Accumulating evidence indicates that VNUT-dependent ATP exocytosis contributes to inflammatory signaling, sensory transmission, metabolic dysregulation, and cancer-related processes, while its inhibition shows therapeutic potential in experimental models of pathological states. This review summarizes recent advances in the molecular basis, regulation, pharmacological manipulation, and disease relevance of VNUT-mediated ATP exocytosis. We also discuss the therapeutic potential of targeting exocytosed ATP for pain, chronic inflammation, and metabolic disorders.

Schlagwörter

Stichwörter der Autor:innen

ATP exocytosisSLC17A9chronic inflammationexocytosed ATPmetabolic disorderspainpurinergic signalingvesicular nucleotide transporter (VNUT)

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Department of Medical Biochemistry, Kurume University School of Medicine, Kurume, Japan.

Zitieren

APA

Hasuzawa, N., Nomura, S., Moriyama, S., Moriyama, Y., & Nomura, M. (2026). Exocytosed ATP as a therapeutic target for inflammatory and metabolic diseases. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1856512

Vancouver

Hasuzawa N, Nomura S, Moriyama S, Moriyama Y, Nomura M. Exocytosed ATP as a therapeutic target for inflammatory and metabolic diseases. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1856512

BibTeX
@article{Hasuzawa2026,
  author = {Hasuzawa, Nao and Nomura, Seiji and Moriyama, Sawako and Moriyama, Yoshinori and Nomura, Masatoshi},
  title = {Exocytosed ATP as a therapeutic target for inflammatory and metabolic diseases},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1856512}
}
Kostenlos starten →